A west nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial

Julie E. Ledgerwood, Theodore C. Pierson, Sarah A. Hubka, Niraj Desai, Steve Rucker, Ingelise J. Gordon, Mary E. Enama, Steevenson Nelson, Martha Nason, Wenjuan Gu, Nikkida Bundrant, Richard A. Koup, Robert T. Bailer, John R. Mascola, Gary J. Nabel, Barney S. Graham

Research output: Contribution to journal › Article › peer-review